IRA & Medicare drug price negotiation
Blum says Congress should review Part D financing after IRA’s rapid changes to the program
USC SchaefferTopic alignment 86
Filed under
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS finalizes rule to codify Medicare Drug Price Negotiation Program
AHATopic alignment 95
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 90
How the Biosimilars Access and Affordability Act Redefines IRA Delays
The Center for BiosimilarsTopic alignment 92